A 39-year-old male presented to our clinic because of nocturnal intermittent palpitation for 2 years. His medical history showed a high blood pressure of 200/100 mm Hg. Transthoracic echocardiography revealed a 54×46-mm mass in the right atrium ([Figure 1a](#F1){ref-type="fig"}, [1b](#F1){ref-type="fig"}). In addition, cardiac magnetic resonance imaging confirmed the tumor and highly suggested it to be a malignant tumor ([Figure 1c](#F1){ref-type="fig"}, [1d](#F1){ref-type="fig"}). An almost 50-fold increase in the blood catecholamine metabolites was detected. Further, positron emission tomography/computed tomography found no other tumor. Given the symptoms and the functional intra-atrial tumor, surgical removal was agreed by our surgical team and the family. During the surgery, we found that the tumor had invaded into the right atrial wall and inter-atrial septum ([Figure 1e](#F1){ref-type="fig"}, [1f](#F1){ref-type="fig"}). Following the complete removal of the tumor, we reconstructed the right atrium and inter-atrial septum with bovine pericardium. Intraoperative echocardiography showed no shunt between the atria and reflow of the pulmonary veins were clear. Pathological analysis revealed the tumor to be a paraganglioma with negative CK and EMA expressions and positive CD56, Syn, and S-100 expressions ([Figure 1g](#F1){ref-type="fig"}--[1i](#F1){ref-type="fig"}). The patient fully recovered and was discharged on postoperative day 7 with a normal blood pressure. At the 6-month follow-up, the patient was still free of symptoms and catecholamine metabolites were normal. Intra-atrial paraganglioma is an extremely rare and functional primary cardiac neoplasm, and our experience suggests multimodality evaluations and complete surgical removal be performed.

![Transthoracic echocardiography images showed a tumor in the right atrium (a, b). Cardiac magnetic resonance imaging showed an equal T1 and long T2 signal shadow in the right atrium, which was suspected as a malignant tumor (c, d). Intraoperative images and the gross anatomy of the tumor (e, f). Immunohistochemical study of the tumor for CD56 expression (g). Immunohistochemical study of the tumor for Syn expression (h). Immunohistochemical study of the tumor for S-100 expression (i)](AJC-19-E2-g001){#F1}
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